Company research
NuCana plc
CIK 1709626Updated Sep 24, 2026
SecurityNCNA · NASDAQ · adr
Name history
NuCana BioMed Ltd · through Aug 4, 2017
NCNA price & chart
Loading TradingView…
NASDAQ:NCNA on TradingView ↗In the news
No coverage from other publishers is available.
Recent filings
Financials
FY 2025 · GBPSource
Source
cash flow · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Profit or LossGBP | -29,353,000Source | -18,997,000Source | -27,632,000Source | -32,021,000Source |
| Additional Financial Items | ||||
| AdjustmentsForDeferredTaxOfPriorPeriodsGBP | 3,535,000Source | 1,746,000Source | 2,715,000Source | 2,711,000Source |
| AdjustmentsForFinanceIncomeGBP | 386,000Source | 358,000Source | 754,000Source | 669,000Source |
| AdjustmentsForIncomeTaxExpenseGBP | -1,168,000Source | -3,454,000Source | -4,398,000Source | -6,432,000Source |
| AdjustmentsForIncreaseDecreaseInTradeAccountPayableGBP | -2,183,000Source | -670,000Source | -1,428,000Source | 2,974,000Source |
| AdjustmentsForSharebasedPaymentsGBP | 10,028,000Source | 1,646,000Source | 3,857,000Source | 4,890,000Source |
| AdjustmentsForUnrealisedForeignExchangeLossesGainsGBP | 194,000Source | -369,000Source | 1,176,000Source | -5,014,000Source |
| IncomeTaxesPaidRefundClassifiedAsOperatingActivitiesGBP | -3,988,000Source | -4,015,000Source | -5,595,000Source | -7,220,000Source |
| IncreaseDecreaseInWorkingCapitalGBP | 3,672,000Source | 2,183,000Source | 1,281,000Source | -3,723,000Source |
| PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivitiesGBP | 54,000Source | 223,000Source | 270,000Source | 227,000Source |
| ProceedsFromIssuingSharesGBP | 20,185,000Source | 8,729,000Source | 249,000Source | — |
| PurchaseOfIntangibleAssetsClassifiedAsInvestingActivitiesGBP | 193,000Source | 289,000Source | 474,000Source | 506,000Source |
income statement · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Additional Financial Items | ||||
| AdministrativeExpenseGBP | 8,096,000Source | 4,988,000Source | 6,063,000Source | 7,291,000Source |
| BasicEarningsLossPerShareGBP/shares | 0Source | -0.26Source | -0.53Source | — |
| DeferredTaxExpenseIncomeRecognisedInProfitOrLossGBP | -12,000Source | 32,000Source | -47,000Source | -34,000Source |
| DepreciationRightofuseAssetsGBP | 65,000Source | 207,000Source | 212,000Source | 251,000Source |
| DilutedEarningsLossPerShareGBP/shares | 0Source | -0.26Source | -0.53Source | — |
| EmployeeBenefitsExpenseGBP | 15,056,000Source | 7,025,000Source | 10,819,000Source | 12,353,000Source |
| ExpenseFromSharebasedPaymentTransactionsWithEmployeesGBP | 10,000,000Source | 1,600,000Source | 3,900,000Source | 4,900,000Source |
| ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsedGBP | 520,000Source | 0Source | 4,000Source | 480,000Source |
| ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsedGBP | 54,000Source | 223,000Source | 270,000Source | 227,000Source |
| ExpenseRelatingToVariableLeasePaymentsNotIncludedInMeasurementOfLeaseLiabilitiesGBP | 0Source | 0Source | 6,000Source | 6,000Source |
| FinanceCostsGBP | 12,648,000Source | — | — | — |
| FinanceIncomeGBP | 386,000Source | 358,000Source | 754,000Source | 669,000Source |
| IncomeTaxExpenseContinuingOperationsGBP | -1,168,000Source | -3,454,000Source | -4,398,000Source | -6,432,000Source |
| InterestExpenseOnLeaseLiabilitiesGBP | 20,000Source | 17,000Source | 29,000Source | 21,000Source |
| OtherIncomeGBP | 2,692,000Source | — | — | — |
| ProfitLossBeforeTaxGBP | -30,521,000Source | -22,451,000Source | -32,030,000Source | -38,453,000Source |
| ProfitLossFromOperatingActivitiesGBP | -20,110,000Source | -22,809,000Source | -32,784,000Source | -39,122,000Source |
| ResearchAndDevelopmentExpenseGBP | 12,737,000Source | 18,017,000Source | 25,062,000Source | 36,426,000Source |